Does a routine invasive strategy improve long-term outcomes compared to a selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes?
The long-term benefit of a routine invasive strategy in NSTE-ACS is attenuated in patients <65 years and women due to early events, though without consequence for long-term cardiovascular mortality.
The current analysis of the FIR dataset shows that the long-term benefit of the routine invasive strategy over the selective invasive strategy is attenuated in younger patients aged <65 years and in women by the increased risk of early events which seem to have no consequences for long-term cardiovascular mortality. No other clinical risk factors were able to identify patients with differential responses to a routine invasive strategy. Trial registration http://www.controlled-trials.com/ISRCTN82153174 (ICTUS), http://www.controlled-trials.com/ISRCTN07752711 (RITA-3).
Damman et al. (Mon,) studied this question.